The Brutalist Report - business
- Should You Buy Figma Stock After Its 59% Drop Since August? [125d]
- Dollar gains against peers after Powell's cautious rate outlook [125d]
- FTX Recovery Trust Sues Genesis Digital to Recover $1.15 Billion [125d]
- Keurig Dr Pepper Moves to Acquire JDE Peet’s While Planning Company Split and Sustaining Dividend [125d]
- Exxon Mobil Boosts Q2 Performance While Acquiring Superior Graphite and Strengthening Dividend [125d]
- Coterra Energy Reports Strong Q2 Growth Despite Lowered Price Targets and Boosts Dividend Appeal [125d]
- Phillips 66 Expands Refining Capacity and Strengthens Dividend Outlook Following Q2 Beat [125d]
- Merck Gains FDA Approval for KEYTRUDA QLEX and Supports Dividend Appeal [125d]
- Chevron Advances with Hess Acquisition and Divestiture Plans While Maintaining Dividend Appeal [125d]
- Pfizer Raises EPS Guidance and Expands Cost-Cutting Plan While Boosting Dividend Appeal [125d]
- Ray Dalio Warns Of 'Very, Very Dark Times,' Says Learning To 'Diversify My Bets' Was The Key To Success: 'A Smart Rabbit Has Three Holes' [125d]
- Wall Street Is Eating Up This Dividend Stock. Should You Buy Shares Before They Surge as Much as 30%? [125d]
- These 3 Dividend Stocks Just Raised Their Payouts by Double Digits [125d]
- Stablecoin Titan Tether Seeks $500 Billion Valuation on $20 Billion Raise: Report [125d]
- Hoth Therapeutics, Inc. (HOTH) Files EMA Application for Global Expansion of HT-001 Skin Therapy [125d]
- Invivyd, Inc. (IVVD) Secures FDA Path for COVID-19 Antibody Approval [125d]
- Entero Therapeutics, Inc. (ENTO) Names Jason D. Sawyer as New CEO Amid Strategic Shift [125d]
- Relmada Therapeutics, Inc. (RLMD) Advances Oncology and CNS Therapies with Promising Phase 2 Data [125d]
- Tiziana Life Sciences Ltd (TLSA) Secures U.S. DoD Grant to Advance Intranasal Foralumab for Spinal Cord Injury [125d]
- NovaBay Pharmaceuticals, Inc. (NBY) Declares $0.80 Special Dividend, Boosting Shareholder Value [125d]
- Lineage Cell Therapeutics, Inc. (LCTX) Shows Vision Gains in Phase 1/2a OpRegen Trial [125d]
- Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization [125d]
- Gossamer Bio, Inc. (GOSS) Stock Jumps 18% on FDA Updates and Seralutinib Progress [125d]
- Matinas BioPharma Holdings, Inc. (MTNB) Restructures Amid Challenges, Focuses on Oral Antifungal MAT2203 [125d]
- Galectin Therapeutics Inc. (GALT) Surges on Promising Belapectin Trial Data and Strong Financials [125d]
- Atai Life Sciences N.V. (ATAI) Advances Psychedelic Therapies for Mental Health, Drawing Investor Spotlight [125d]
- MindWalk Holdings Corp. (HYFT) Surges with 45% Revenue Growth and Strategic AI-Focused Rebrand [125d]
- I-Mab (IMAB) Shows 83% Response Rate for Givastomig in Metastatic Gastric Cancer [125d]
- ABVC BioPharma, Inc. (ABVC) Reports 103% Asset Surge, Eyeing Phase III Trials for Depression Therapies [125d]
- Jazz Pharmaceuticals plc (JAZZ) Advances Rare Cancer Portfolio with First CNS Glioma Therapy Approval [125d]
- Elanco Animal Health Incorporated (ELAN) Joins S&P MidCap 400 Following Strong Q2 Growth and Product Ramp-Up [125d]
- Royalty Pharma plc (RPRX) Completes $2B Senior Notes Offering, Strengthens Capital for Growth [125d]
- Viatris Inc. (VTRS) Gains FDA Approval for First Generic Iron Sucrose Injection [125d]
- Pfizer Inc. (PFE) Targets $4.5B in Cost Savings to Fuel R&D and Innovative Therapies [125d]
- Powering AI: From CERA Week Optimism to New York Climate Week Realism [125d]
- Stock market today: Nasdaq, S&P 500 futures pop while Dow holds steady as Alibaba spreads AI cheer [125d]
- Stock market today: Nasdaq, Dow, S&P 500 rise as Alibaba spreads AI cheer [125d]
- Stock market today: Nasdaq, Dow, S&P 500 waver with divided Fed, Alibaba in focus [125d]
- Stock market today: Nasdaq, Dow, S&P 500 fall with divided Fed, Alibaba in focus [125d]
- EMA Gives Positive Opinion on Zoetis Inc. (ZTS)’ Cat Arthritis Therapy, Portela [125d]
- Merck & Co., Inc. (MRK) Received FDA Approval For Keytruda Qlex, Cutting Infusion Time to 2 Minutes [125d]
- Why Crane NXT Stock Surged by 15% Today [125d]
- Bristol-Myers Squibb Company (BMY) to Divest 60% China JV Amid Strategic Realignment [125d]
- Johnson & Johnson (JNJ) Gains FDA Nod for Subcutaneous Tremfya in Ulcerative Colitis [125d]
- Eli Lilly and Company (LLY) Unveils $5B Virginia Facility to Ramp Up Bioconjugate and Monoclonal Antibody Production [125d]
- Retirement Fear Is Real: 64% Worry More About Running Out Of Money Than Death Itself [125d]
- Is Iraq Looking To Open Another Backdoor For Iran To Export Its Oil? [125d]
- No new articles in the Past Hour.
- No new articles in the Past Hour.
- No new articles in the Past Hour.
- No new articles in the Past Hour.
- No new articles in the Past Hour.
Previous Day